Preeclampsia Laboratory Testing Market Size to grow by USD 855.3 million between 2024-2028
According to a research report “ Preeclampsia Laboratory Testing Market” by Product Type (Consumables, Instruments) Test (Blood test, Urine test, Others) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 855.3 million, at a CAGR of 8.09% during the forecast period. In emerging economies such as China, India, and Brazil, the need for preeclampsia laboratory testing is escalating due to the rising incidence of health complications for mothers and fetuses. Factors contributing to this trend include an increase in high-risk pregnancies resulting from conditions like kidney and liver disorders, high blood pressure, liver damage, UTIs, chromosomal abnormalities, and multifetal pregnancies. Additionally, factors such as growing awareness of healthcare devices, substantial investments in the private healthcare sector, government initiatives to develop the healthcare industry, and ongoing research for advanced preeclampsia laboratory testing are fueling market expansion in these regions.
Browse market data tables, figures, and in-depth TOC on “Preeclampsia Laboratory Testing Market” by Product Type (Consumables, Instruments) Test (Blood test, Urine test, Others) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample
By Product Type, the Consumables segment is projected to dominate the market size in 2024
In the context of pregnancy health monitoring, laboratory testing plays a crucial role in identifying potential complications, including preeclampsia. For pregnant women between 20 and 35 weeks, doctors may recommend a blood test to assess liver and kidney function, as well as platelet count. A key indicator of preeclampsia is a decreased placental growth factor (PIGF) level in the blood. If detected, further tests are necessary for confirmation. Severe preeclampsia symptoms warrant a repeat blood test to observe changes in liver function and platelet counts. This professional and timely approach to testing ensures effective diagnosis and appropriate care for pregnant women.
By Test, Blood test segment is expected to hold the largest market size for the year 2024
In the realm of preeclampsia laboratory testing, consumables and reagents play essential roles. Consumables, being indispensable components, facilitate the selection and enrichment of testing procedures. Reagents, on the other hand, are chemical substances or mixtures utilized during these procedures, offering users an intuitive interface. The consumable segment experiences significant growth due to their relatively low cost and high usage frequency. Revenue generation is further bolstered through device rentals in laboratories, with consumables being purchased on a yearly basis under agreed terms. A noteworthy trend emerges as laboratories and hospitals increasingly opt for online purchasing of consumables, thereby fueling global online sales.
North America is forecasted to hold the largest market size by region in 2024
The Preeclampsia Laboratory Testing Market encompasses the production, sale, and distribution of diagnostic tests used to identify preeclampsia in pregnant women. Market growth is driven by the rising prevalence of preeclampsia, advancements in testing technologies, and increasing awareness and early diagnosis initiatives. Key players in this market include Roche Diagnostics, Siemens Healthineers, and Abbott Laboratories. These companies invest in research and development to offer accurate and efficient testing solutions to healthcare providers.
The Preeclampsia Laboratory Testing Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:
.
For insights on company offerings- Request a sample report!
Research Analysis Overview
Preeclampsia, a pregnancy complication characterized by high blood pressure and organ dysfunction, primarily affects pregnant women. Early detection is crucial for effective disease management and ensuring the health and safety of both mother and baby. Medical technologies have advanced to offer various laboratory tests for preeclampsia diagnosis, including those for kidney and liver function, blood pressure monitoring, and detection of proteinuria. The increasing prevalence of lifestyle disorders and teenage pregnancy rates, as well as co-occurring conditions like malaria and infections, necessitate novel diagnostic technologies. POC (Point of Care) products and personalized medicinal products are gaining popularity due to their convenience and ability to provide quick results. Antenatal care centers are integrating these advanced diagnostic tools to improve patient satisfaction and treatment adherence. Raw materials suppliers play a vital role in ensuring the availability and quality of these diagnostic reagents and supplies. The preeclampsia laboratory testing market is poised for growth, driven by the increasing global population and the need for effective disease management. Continuous innovation in diagnostic technologies and the integration of AI and machine learning algorithms will further enhance the accuracy and accessibility of preeclampsia testing.
Market Research Overview
Preeclampsia, a pregnancy complication characterized by hypertension and organ dysfunction, can lead to serious health consequences for both the mother and the baby. Diagnostic laboratories play a crucial role in the early detection and diagnosis of preeclampsia through various blood tests. Calcium supplements and aspirin doses are often prescribed as medical interventions to prevent preeclampsia in high-risk pregnancies. The disease pathogenesis of preeclampsia involves various biomarkers such as placental growth factor, soluble fms-like tyrosine kinase-1, and angiotensin II. Precision and early detection are essential for effective disease management, leading to the increasing use of novel technologies like POC products and personalized medicinal products. Pregnant women are at risk of preeclampsia due to lifestyle disorders, teenage pregnancy rates, and infections like malaria. Hospitals, clinics, and diagnostic centers offer antenatal care services to monitor blood pressure, kidney, and liver function, and diagnose preeclampsia. Health insurance policies and patient advocacy groups also contribute to increasing awareness and ensuring treatment adherence and patient satisfaction. Raw materials and consumables used in preeclampsia laboratory testing require stringent quality control measures to ensure health and safety. The global preeclampsia laboratory testing market is expected to grow due to the increasing population, rising awareness of preeclampsia, and the development of advanced medical technologies.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
